|
Prescription Drug Search
Strengths available for Zomig:
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about CancerDrugsDirect.com
List of countries where we can ship Zomig:
- Anguilla
- Antigua and Barbuda
- Australia
- Belgium
- Bulgaria
- Cayman Islands
- Chile
- Croatia
- Cuba
- Denmark
- Egypt
- Finland
- Greece
- Greenland
- Grenada
- Guadeloupe
- Hungary
- Iceland
- India
- Indonesia
- Iran
- Ireland
- Japan
- Jordan
- Kuwait
- Luxembourg
- New Zealand
- Nicaragua
- Norway
- Qatar
- Saudi Arabia
- Seychelles
- South Africa
- Sri Lanka
- Sweden
- Switzerland
- United Kingdom, UK
- United States, US
- Vanuatu
- Vietnam
Latest news releases on Zomig:
Glenmark Gets USFDA Tentative Nod For Zolmitriptan Orally Disintegrating Tablets - RTT News
(RTTNews) - Glenmark Pharmaceuticals Ltd. said its US subsidiary Glenmark Generics Inc. has obtained tentative approval from US FDA for Zolmitriptan orally disintegrating tablets, its generic version of AstraZeneca's Zomig-ZMT tablets. The tentative ...
Glenmark Generics receives tentative U.S. FDA approval for zolmitriptan orally disintegrating tablets - equitybulls.com
its generic version of AstraZeneca’s Zomig-ZMT® Tablets. The tentative approval is for the 2.5 mg and 5 mg orally disintegrating tablets of zolmitriptan and constitutes one of the first tentative approvals granted by the FDA for a generic ...
Glenmark Generics gets US FDA tentative nod for zolmitriptan tablets - pharmabiz.com
the generic version of AstraZeneca's Zomig-ZMT tablets. The tentative approval is for the 2.5 mg and 5 mg orally disintegrating tablets of zolmitriptan and consitutes one of the first tentative approvals granted by the FDA for a generic vesion of the drug.
Impax Laboratories Reports Adjusted First Quarter 2012 EPS of $0.52; GAAP EPS of $0.18 - Boston Globe
“During the first quarter of 2012, we established the infrastructure to successfully transition the U.S. commercial opportunity for Zomig® from AstraZeneca to our brand division. The transaction was accretive to our first quarter non-GAAP ...
Glenmark gets tentative nod from USFDA for migraine tablets - MSN India
The approval is for zolmitriptan tablets in the strengths of 2.5 mg and 5 mg, Glenmark said. The tablets are generic version of AstraZeneca''s Zomig-ZMT tablets, it added. Earlier in in September 2011, the company had received tentative approval for ...
